The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 10, 2018

Filed:

Jan. 09, 2017
Applicant:

Seecure Taiwan Co., Ltd., Kaohsiung, TW;

Inventors:

Wei-Chung Chang, Kaohsiung, TW;

Kun-Hsin Lee, Kaohsiung, TW;

Kai-Chi Chang, Kaohsiung, TW;

Ping-Fan Chen, Kaohsiung, TW;

Min-Huei Huang, Kaohsiung, TW;

Hung-Yuan Huang, Kaohsiung, TW;

Ning Tsao, Kaohsiung, TW;

Assignee:

SeeCure Taiwan Co., Ltd., Kaohsiung, TW;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/196 (2006.01); A61K 31/198 (2006.01); A61K 51/04 (2006.01); A61K 31/519 (2006.01); A61K 31/337 (2006.01); A61K 31/4164 (2006.01); A61K 31/704 (2006.01); A61K 31/522 (2006.01); A61K 39/395 (2006.01); A61K 31/203 (2006.01); A61K 38/06 (2006.01); A61K 38/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0497 (2013.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/203 (2013.01); A61K 31/337 (2013.01); A61K 31/4164 (2013.01); A61K 31/519 (2013.01); A61K 31/522 (2013.01); A61K 31/704 (2013.01); A61K 38/06 (2013.01); A61K 38/12 (2013.01); A61K 39/3955 (2013.01); A61K 2039/505 (2013.01);
Abstract

A compound represented by formula (I) is provided, wherein in formula (I), Rand Reach independently represents hydrogen, O—Ror S—R, at least one of Rand Ris O—Ror S—R, and Rand Rare independently a Cto Calkyl group, such that the Cto Calkyl group is non-substituted or substituted with at least one selected from the group consisting of —OH, —NH, halogen, ester, ether, and carboxylic acid, and M being a metal or a metal-containing compound. The compound represented by formula (I) is shown to have higher specificity to tumor cells, and is therefore suitable for carrying anti-cancer drugs and/or nuclear imaging agents.


Find Patent Forward Citations

Loading…